Table 1 Distribution of hemoglobinopathies among patients investigated at Aga Khan Hospital, Kisumu, in Kenya
➢Location | Hemoglobinopathies | Total | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
SCD | SCD-HHBF | SCD-beta thalassemia | SCT | SCT-HBF | SCT-beta thalassemia | Beta thalassemia | ||||
Busia | 7 (2.8%) | 4(1.6%) | 11 (4.5%) | 27 (10.9%) | 2 (0.8%) | 1(0.4%) | 1 (0.4%) | 53 (21.5% | ||
Bungoma | 1 (0.4%) | 1 (0.4%) | 7 (2.8%) | 5 (2.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 14 (5.7%) | ||
Kitale | 2 (0.8%) | 3 (1.2%) | 3 (1.2%) | 2 (0.8%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 10 (4.0%) | ||
Kakamega | 4 (1.6%) | 3 (1.2%) | 0 (0.0%) | 3 (1.2%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 10 (4%) | ||
Kisumu | 25 (10.1%) | 7 (2.8%) | 31 (12.6%) | 30 (12.1%) | 0 (0.0%) | 3 (1.2%) | 6 (2.4%) | 102 (41.3%) | ||
Kisii | 0 (0.0%) | 1 (0.4%) | 4 (1.6%) | 5 (2.0%) | 0 (0.0%) | 0(0.0%) | 0(0.0%) | 10 (4.0%0 | ||
Homabay | 4 (1.6%) | 1 (0.4%) | 6 (2.4%) | 24 (9.7%) | 0 (0.0%) | 2 (0.8%) | 1 (0.4%) | 38 (15.4%) | ||
Migori | 2(0.8%) | 0 (0.00%) | 0 (0.0%) | 7 (2.8%) | 0 (0.0%) | 0(0.0%) | 1 (0.4%) | 10 (4.0%) | ||
Gender | Male | 20 (8.1%) | 5 (2.0%) | 28 (11.3%) | 48 (19.4%) | 1 (0.4%) | 5 (2.0%) | 5 (2.0%) | 112 (45.3%) | |
Female | 25 (10.1%) | 15 (6.1%) | 34 (13.8%) | 55 (22.3%) | 1 (0.4%) | 1 (0.4%) | 4 (1.6%) | 135 (54.7%) | ||
Age (years) | 0–5 years | 17 (6.9%) | 12 (4.9%) | 33 (13.4%) | 53 (21.5%) | 2 (0.8%) | 4 (1.6%) | 4 (1.6%) | 125 (50.6%) | |
6–12 years | 16 (6.5%) | 5 (2.0%) | 19 (7.7%) | 18 (7.3%) | 0 (0.0%) | 0 (0.0%) | 2 (0.8%) | 60 (24.3%) | ||
> 13 years | 12 (4.9%) | 3 (1.2%) | 10 (4.0%) | 32 (13.0%) | 0 (0.0%) | 2 (0.8%) | 3 (1.2%) | 62 (25.1%) | ||
Overall hemoglobinopathies | 45 (18.2%) | 20 (8.1%) | 62 (25.1%) | 103 (41.7%) | 2 (0.8%) | 6 (2.4%) | 9 (3.6%) | 247 (100%) | ||